submitted by nelsonam@augsburg.edu
Help Advance Research on Neurodegenerative Disorders
What is the goal of the study?
The purpose of this study is to find out whether insulin, a drug approved by the FDA for
the treatment of diabetes mellitus, reaches the brain and spinal cord when delivered as a
nasal spray (intranasally).
What happens in the study?
· There will be 3 in-person visits (lasting 2-4 hours) and one phone call
· At Visit 2, you will receive one dose of intranasal insulin and undergo a lumbar
puncture (spinal tap).
Where will the study take place?
HealthPartners Neuroscience Center
295 Phalen Boulevard,
St. Paul, MN 55130
and
Regions Hospital
640 Jackson St.
St. Paul 55101
You may be eligible if:
You are between the ages of 18 and 35
You are willing/able to have a lumbar puncture
What is the cost?
All study related procedures will be paid for with research funds. Participants will be paid for completing study visits.
Contact the study team:Call: (651) 495-6363 or email clinicaltrials@healthpartners.com
https://clinicaltrials.gov/study/NCT05866367?term=NCT05866367&rank=1